Form 4: Natera Director Baynes Sells Shares Under 10b5-1 Plan

Natera Director Roy D. Baynes executed multiple stock option exercises and subsequent sales of common stock, reducing his direct beneficial ownership by 5,112 shares.

Summary

• Director Roy D. Baynes engaged in a series of transactions involving Natera, Inc. common stock on November 19 and 20, 2025.
• Transactions included exercising stock options and selling common stock, all conducted under a Rule 10b5-1 trading plan adopted on August 20, 2025.
• On November 19, 2025, Baynes exercised options for 5,112 shares at $40.93 and subsequently sold 5,112 shares at weighted average prices ranging from $213.471 to $216.0673.
• On November 20, 2025, Baynes exercised options for 600 shares at $40.93 and 7,068 shares at $41.19, and subsequently sold 7,668 shares at weighted average prices ranging from $220.1402 to $224.886.
• The net effect of these reported transactions resulted in a decrease of 5,112 shares in his direct beneficial ownership, from an initial reported 23,471 shares to 18,359 shares.
• After these transactions, 600 stock options with an exercise price of $40.93 and an expiration date of June 11, 2030, remain beneficially owned.

Sentiment

Score: 5

Explanation: Neutral. This is a routine insider transaction report (Form 4) detailing option exercises and sales under a 10b5-1 plan. While a reduction in beneficial ownership can sometimes be viewed negatively, the pre-planned nature and the fact that it's an exercise-and-sell transaction for personal liquidity or diversification makes it a neutral event from a company performance perspective.

Positives

• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and not reactive disposition of shares.
• The exercise prices of the options ($40.93 and $41.19) are significantly lower than the sale prices (ranging from $213.18 to $224.92), indicating a substantial profit for the director on the exercised shares.

Negatives

• The director's overall direct beneficial ownership decreased by 5,112 shares, which could be perceived as a reduction in insider confidence, although mitigated by the 10b5-1 plan.

Future Outlook

This filing is a transactional report and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This Form 4 filing details an insider transaction, which is a routine disclosure for publicly traded companies. It does not provide information directly related to broader industry trends or competitive landscape, but rather reflects an individual director's personal investment activity.

Comparison to Industry Standards

• This filing reports an insider transaction (exercise and sale of shares) which is standard practice for executives and directors of publicly traded companies.
• The use of a Rule 10b5-1 trading plan is a common and accepted method for insiders to sell shares in a pre-planned, compliant manner, mitigating concerns about trading on material non-public information.
• No specific comparable companies or projects are relevant for this type of individual transaction report.

Stakeholder Impact

• Shareholders: May observe a director reducing their stake, which could be interpreted in various ways, though the 10b5-1 plan mitigates negative implications.
• Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction report.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction where a director exercised stock options and subsequently sold shares under a pre-arranged 10b5-1 trading plan. While the director's direct beneficial ownership decreased by 5,112 shares, the transactions represent a planned liquidity event rather than a reactive sale based on new information. The significant profit realized from the option exercises indicates past stock appreciation. As this filing does not provide new information about the company's operational performance, financial health, or strategic direction, it does not warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting further fundamental company updates.

Keywords

Natera, NTRA, Insider Trading, Form 4, Stock Options, Share Sale, Director Transactions, Rule 10b5-1, Beneficial Ownership